Milestone Pharmaceuticals Inc. SEC filings MIST
Milestone Pharmaceuticals Inc. has 421 filings in SEC EDGAR's recent list, going back to Jul 30, 2007. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Listing notice
|
Oct 28, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Other events
|
Sep 3, 2026 | Sep 3, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 7, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 15, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| EFFECT | Filing | May 22, 2026 | — |
| CORRESP | Letter to the SEC | May 20, 2026 | — |
| UPLOAD | Letter from the SEC | May 18, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| S-3 | Shelf registration | May 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 13, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Apr 20, 2026 | Apr 16, 2026 |
| 144 | Notice of proposed sale | Apr 16, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| 3 | Initial insider ownership | Mar 23, 2026 | Mar 17, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 20, 2026 | Mar 20, 2026 |
| 10-K | Annual report | Mar 20, 2026 | Dec 31, 2025 |
| 4/A | Filing | Feb 5, 2026 | Feb 2, 2026 |
| 4/A | Filing | Feb 5, 2026 | Feb 2, 2026 |
| 4/A | Filing | Feb 5, 2026 | Feb 2, 2026 |
| 4/A | Filing | Feb 5, 2026 | Feb 2, 2026 |
| 4/A | Filing | Feb 5, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Jan 28, 2026 | Dec 12, 2025 |
| 4 | Insider transaction | Jan 28, 2026 | Dec 12, 2025 |
| 4 | Insider transaction | Jan 28, 2026 | Dec 12, 2025 |
| 4 | Insider transaction | Jan 28, 2026 | Dec 12, 2025 |
| 4 | Insider transaction | Jan 28, 2026 | Dec 12, 2025 |
| 8-K |
Current report
Other events
|
Jan 26, 2026 | Jan 26, 2026 |
| 8-K |
Current report
Other events
|
Jan 13, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 7, 2026 |
| 144 | Notice of proposed sale | Jan 8, 2026 | — |
| 144 | Notice of proposed sale | Jan 7, 2026 | — |
| 8-K |
Current report
Other events
|
Jan 6, 2026 | Jan 6, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 23, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 15, 2025 | Dec 12, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 13, 2025 | — |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| S-8 | Employee stock plan registration | Aug 12, 2025 | — |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 21, 2025 | — |
| 4 | Insider transaction | Jul 15, 2025 | Jul 11, 2025 |
| 4 | Insider transaction | Jul 15, 2025 | Jul 11, 2025 |
| 4 | Insider transaction | Jul 15, 2025 | Jul 11, 2025 |
| 4 | Insider transaction | Jul 15, 2025 | Jul 11, 2025 |
| 4 | Insider transaction | Jul 15, 2025 | Jul 11, 2025 |
| 4 | Insider transaction | Jul 15, 2025 | Jul 11, 2025 |
| 4 | Insider transaction | Jul 15, 2025 | Jul 11, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 14, 2025 | Jul 11, 2025 |
| 424B5 | Prospectus supplement | Jul 14, 2025 | — |
| 424B5 | Prospectus supplement | Jul 11, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jul 11, 2025 | Jul 10, 2025 |
| 8-K |
Current report
Other events
|
Jun 16, 2025 | Jun 16, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| ARS | Annual report to shareholders | Apr 30, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 30, 2025 | — |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 10, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 30, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 22, 2025 | — |
| 8-K |
Current report
Other events
|
Mar 28, 2025 | Mar 28, 2025 |
| 8-K | Current report | Mar 19, 2025 | Mar 18, 2025 |
| 424B5 | Prospectus supplement | Mar 18, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Mar 18, 2025 | Mar 18, 2025 |
| S-8 | Employee stock plan registration | Mar 13, 2025 | — |
| 8-K |
Current report
Results of operations
|
Mar 13, 2025 | Mar 13, 2025 |
| 10-K | Annual report | Mar 13, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 25, 2025 | Feb 25, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2025 | — |
| 4 | Insider transaction | Jan 29, 2025 | Jan 27, 2025 |
| 4 | Insider transaction | Jan 29, 2025 | Jan 27, 2025 |
| 4 | Insider transaction | Jan 29, 2025 | Jan 27, 2025 |
| 4 | Insider transaction | Jan 29, 2025 | Jan 27, 2025 |
| 4 | Insider transaction | Jan 29, 2025 | Jan 27, 2025 |
| EFFECT | Filing | Nov 22, 2024 | — |
| CORRESP | Letter to the SEC | Nov 20, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 19, 2024 | — |
| S-3 | Shelf registration | Nov 12, 2024 | — |
| S-8 | Employee stock plan registration | Nov 12, 2024 | — |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 29, 2024 | — |
| 4 | Insider transaction | Sep 5, 2024 | Sep 3, 2024 |
| 3 | Initial insider ownership | Sep 5, 2024 | Sep 3, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
|
Sep 4, 2024 | Aug 28, 2024 |
| 4 | Insider transaction | Aug 29, 2024 | Aug 28, 2024 |
| 4 | Insider transaction | Aug 29, 2024 | Aug 28, 2024 |
| 4 | Insider transaction | Aug 29, 2024 | Aug 28, 2024 |
| 4 | Insider transaction | Aug 29, 2024 | Aug 28, 2024 |
| 4 | Insider transaction | Aug 29, 2024 | Aug 28, 2024 |
| 4 | Insider transaction | Aug 29, 2024 | Aug 28, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 4 | Insider transaction | Jul 17, 2024 | Jul 15, 2024 |
| 3 | Initial insider ownership | Jul 17, 2024 | Jul 15, 2024 |
| 4 | Insider transaction | Jul 17, 2024 | Jul 15, 2024 |
| 3 | Initial insider ownership | Jul 17, 2024 | Jul 15, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Jul 16, 2024 | — |
| ARS | Annual report to shareholders | Jul 15, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Jul 15, 2024 | — |
| DEFA14A | Additional proxy material | Jul 15, 2024 | — |
| DEF 14A | Proxy statement | Jul 15, 2024 | Aug 28, 2024 |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Jul 15, 2024 | Jul 14, 2024 |
| 8-K |
Current report
Other events
|
May 29, 2024 | May 29, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| 10-K/A | Amended annual report | Apr 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Other events
|
Apr 8, 2024 | Apr 8, 2024 |
| 8-K |
Current report
Other events
|
Mar 28, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 21, 2024 | Mar 21, 2024 |
| 10-K | Annual report | Mar 21, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 4, 2024 | Feb 28, 2024 |
| 424B5 | Prospectus supplement | Mar 1, 2024 | — |
| 424B5 | Prospectus supplement | Feb 28, 2024 | — |
| 8-K |
Current report
Other events
|
Feb 26, 2024 | Feb 26, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 29, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 24, 2024 | — |
| 8-K |
Current report
Other events
|
Dec 26, 2023 | Dec 26, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 13, 2023 | Nov 11, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| SC 13D | Ownership over 5% (active) | Nov 9, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 7, 2023 | Nov 7, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 24, 2023 | Oct 24, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 9, 2023 | Jun 7, 2023 |
| 4 | Insider transaction | Jun 9, 2023 | Jun 7, 2023 |
| 4 | Insider transaction | Jun 9, 2023 | Jun 7, 2023 |
| 4 | Insider transaction | Jun 9, 2023 | Jun 7, 2023 |
| 4 | Insider transaction | Jun 9, 2023 | Jun 7, 2023 |
| 4 | Insider transaction | Jun 9, 2023 | Jun 7, 2023 |
| 4 | Insider transaction | Jun 9, 2023 | Jun 7, 2023 |
| 424B5 | Prospectus supplement | May 31, 2023 | — |
| 10-K/A | Amended annual report | May 31, 2023 | Dec 31, 2022 |
| EFFECT | Filing | May 26, 2023 | — |
| CORRESP | Letter to the SEC | May 24, 2023 | — |
| UPLOAD | Letter from the SEC | May 18, 2023 | — |
| S-3 | Shelf registration | May 15, 2023 | — |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| S-8 | Employee stock plan registration | Apr 28, 2023 | — |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 7, 2023 |
| 8-K |
Current report
New debt, Unregistered share sale, Regulation FD disclosure
|
Mar 31, 2023 | Mar 27, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 29, 2023 | Mar 29, 2023 |
| 10-K | Annual report | Mar 29, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 28, 2023 | Mar 27, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Mar 27, 2023 | Mar 21, 2023 |
| 4 | Insider transaction | Mar 24, 2023 | Mar 22, 2023 |
| 4 | Insider transaction | Mar 23, 2023 | Mar 21, 2023 |
| 3 | Initial insider ownership | Mar 23, 2023 | Mar 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 7, 2023 | Mar 7, 2023 |
| 4 | Insider transaction | Feb 17, 2023 | Feb 16, 2023 |
| 4 | Insider transaction | Feb 17, 2023 | Feb 16, 2023 |
| 4 | Insider transaction | Feb 17, 2023 | Feb 16, 2023 |
| 4 | Insider transaction | Feb 17, 2023 | Feb 16, 2023 |
| 4 | Insider transaction | Feb 17, 2023 | Feb 16, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2023 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MIST (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Quebec, Canada
- Headquarters
- Montreal, Quebec, Canada
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1408443
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.